Precision Health Clinical Trials
UW Undiagnosed Genetic Diseases Program
Conditions: Rare Diseases; Genetic Disease; Undiagnosed Disease
Intervention: Diagnostic Test: Trio Whole Genome Sequencing and Participant-Specific Research
Sponsors: University of Wisconsin, Madison; University of Wisconsin Center for Human Genomics and Precision Medicine
Recruiting
Intervention: Diagnostic Test: Trio Whole Genome Sequencing and Participant-Specific Research
Sponsors: University of Wisconsin, Madison; University of Wisconsin Center for Human Genomics and Precision Medicine
Recruiting
For more information, visit the Study URL.
Transcriptional and Immine Parameters of Response to Belinumab
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Belimumab
Sponsor: Biomedical Research Foundation, Academy of Athens
Not yet recruiting
Intervention: Drug: Belimumab
Sponsor: Biomedical Research Foundation, Academy of Athens
Not yet recruiting
For more information, visit the Study URL.
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
Conditions: Biliary Tract Cancer; Cholangiocarcinoma; Gallbladder Cancer; Intrahepatic Cholangiocarcinoma; Perihilar Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma; Hilar Cholangiocarcinoma; Distal Bile Duct Cancer
Intervention: Diagnostic Test: Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
Sponsors: University of Washington; Natera, Inc.; SEngine Precision Medicine, Inc.
Recruiting
Intervention: Diagnostic Test: Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
Sponsors: University of Washington; Natera, Inc.; SEngine Precision Medicine, Inc.
Recruiting
For more information, visit the Study URL.
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
Conditions: Oropharyngeal Squamous Cell Carcinoma; Carcinoma, Squamous Cell; Head and Neck Squamous Cell Carcinoma; Oropharynx Squamous Cell Carcinoma
Intervention:
Sponsors: UNC Lineberger Comprehensive Cancer Center; Mayo Clinic
Recruiting
Intervention:
Sponsors: UNC Lineberger Comprehensive Cancer Center; Mayo Clinic
Recruiting
For more information, visit the Study URL.
Risk of Recurrence of de Novo Mutations: Research and Quantification of Paternal Germinal Mosaicism by the Combined Use of Genomic Tools
Condition: Developmental Disorders
Interventions: Genetic: genome-wide analyses; Genetic: Search for de novo mutations in paternal sperm samples
Sponsor: University Hospital, Rouen
Not yet recruiting
Interventions: Genetic: genome-wide analyses; Genetic: Search for de novo mutations in paternal sperm samples
Sponsor: University Hospital, Rouen
Not yet recruiting
For more information, visit the Study URL.
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Conditions: Advanced Breast Carcinoma; Advanced Gastric Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Prostate Carcinoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Castration-Resistant Prostate Carcinoma; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; HER2-Positive Breast Carcinoma; Metastatic Breast Carcinoma; Metastatic Gastric Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Ovarian Carcinoma; Metastatic Pancreatic Carcinoma; Metastatic Prostate Carcinoma; Pathologic Stage III Gastric Cancer AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIB Gastric Cancer AJCC v8; Pathologic Stage IIIC Gastric Cancer AJCC v8; Pathologic Stage IV Gastric Cancer AJCC v8; Platinum-Sensitive Ovarian Carcinoma; Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8; Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Stage II Pancreatic Cancer AJCC v8; Stage IIA Pancreatic Cancer AJCC v8; Stage IIB Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIA1 Ovarian Cancer AJCC v8; Stage IIIA2 Ovarian Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8
Interventions: Procedure: Biopsy; Drug: Talazoparib
Sponsor: National Cancer Institute (NCI)
Recruiting
Interventions: Procedure: Biopsy; Drug: Talazoparib
Sponsor: National Cancer Institute (NCI)
Recruiting
For more information, visit the Study URL.
ANXA5 M2 Haplotyping in IVF Patients and Embryos
Conditions: Infertility; Miscarriage, Recurrent; Pregnancy Complications
Intervention: Other: M2 Test
Sponsor: Genomic Prediction Inc.
Recruiting
Intervention: Other: M2 Test
Sponsor: Genomic Prediction Inc.
Recruiting
For more information, visit the Study URL.
Sub-study of the Essen Study Centre for the ENTAiER Trial
Conditions: Elderly Patients; Chronically Ill; Increased Risk of Falling
Interventions: Other: Eurythmy Therapy; Other: Tai Chi; Other: Standard Care
Sponsors: Universität Duisburg-Essen; Software AG Stiftung; Universität Freiburg
Not yet recruiting
Interventions: Other: Eurythmy Therapy; Other: Tai Chi; Other: Standard Care
Sponsors: Universität Duisburg-Essen; Software AG Stiftung; Universität Freiburg
Not yet recruiting
For more information, visit the Study URL.
Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma
Condition: Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics
Intervention: Other: No intervention
Sponsor: Ruijin Hospital
Not yet recruiting
Intervention: Other: No intervention
Sponsor: Ruijin Hospital
Not yet recruiting
For more information, visit the Study URL.
Embryo Health Study
Conditions: Infertility; Hereditary Diseases
Intervention: Other: Preimplantation Genetic Testing
Sponsor: Genomic Prediction Inc.
Recruiting
Intervention: Other: Preimplantation Genetic Testing
Sponsor: Genomic Prediction Inc.
Recruiting
For more information, visit the Study URL.